- Presentations
- 4
- Markets
- 1
Procysbi is a brand of Cysteamine marketed by Horizon Therapeutics, with 4 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Cysteamine
- Brand owner
- Horizon Therapeutics
- Registered in
- United States
- Strengths and forms
- 25 mg delayed-release capsule, 75 mg delayed-release capsule, 300 mg delayed-release granules, 75 mg delayed-release granules
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Procysbi 25 mg delayed-release capsuleOral Cold chain | Horizon Therapeutics | US FDA | Available on request |
| Procysbi 75 mg delayed-release capsuleOral Cold chain | Horizon Therapeutics | US FDA | Available on request |
| Procysbi 300 mg delayed-release granulesOral Cold chain | Horizon Therapeutics | US FDA | Available on request |
| Procysbi 75 mg delayed-release granulesOral Cold chain | Horizon Therapeutics | US FDA | Available on request |
Equivalent brands
Other brands of Cysteamine.
Brand names and trademarks belong to their owners and are used only to identify products.
Request Procysbi
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.